BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu J, Li B, Li FY, Ye H, Xiong XZ, Cheng NS. Prognostic significance of mucinous component in hilar cholangiocarcinoma after curative-intent resection. J Surg Oncol 2019;120:1341-9. [PMID: 31612493 DOI: 10.1002/jso.25722] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu ZL, Ou YJ, Dai HS, Wan K, Bie P, Chen ZY, Zhang LD, Zhang CC. Elevated preoperative CA125 levels predicts poor prognosis of hilar cholangiocarcinoma receiving radical surgery. Clin Res Hepatol Gastroenterol 2021;45:101695. [PMID: 34147661 DOI: 10.1016/j.clinre.2021.101695] [Reference Citation Analysis]
2 Zhao J, Zhang W, Zhang J, Zhang Y, Ma WJ, Liu SY, Li FY, Song B. Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection. BMC Cancer 2020;20:849. [PMID: 32883228 DOI: 10.1186/s12885-020-07357-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Ye XW, Hu HJ, Xiong XZ, Lu J, Cheng NS. The preoperative elevated plasma fibrinogen level is associated with the prognosis of hilar cholangiocarcinoma. Surg Today 2021;51:1352-60. [PMID: 33651221 DOI: 10.1007/s00595-021-02249-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Zhang MY, Wang JP, He K, Xia XM. Bsep expression in hilar cholangiocarcinoma of rat model. Sci Rep 2021;11:2861. [PMID: 33536605 DOI: 10.1038/s41598-021-82636-z] [Reference Citation Analysis]
5 Ma WJ, Jin YW, Wu ZR, Yang Q, Wang JK, Liu F, Shi YJ, Li QS, Cheng NS. Meta-analysis of randomized clinical trials of adjuvant chemotherapy for resected biliary tract cancers. HPB (Oxford) 2020;22:939-49. [PMID: 32349925 DOI: 10.1016/j.hpb.2020.02.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
6 Laohawetwanit T, Klaikaew N. Pathological aspects of mucinous cholangiocarcinoma: A single-center experience and systematic review. Pathol Int 2020;70:661-70. [PMID: 32638458 DOI: 10.1111/pin.12983] [Reference Citation Analysis]
7 Pfrepper C, Knödler M, Schorling RM, Seehofer D, Petros S, Lordick F. Predictors for thromboembolism in patients with cholangiocarcinoma. J Cancer Res Clin Oncol 2021. [PMID: 34499224 DOI: 10.1007/s00432-021-03794-1] [Reference Citation Analysis]
8 Chen Y, Zhang B, Liu C, Cao Y, Lyu C, Qiu M. Clinical efficacy of adjuvant treatments for patients with resected biliary tract cancer: a systematic review and network meta-analysis. BMJ Open 2022;12:e051421. [PMID: 35440445 DOI: 10.1136/bmjopen-2021-051421] [Reference Citation Analysis]
9 Macias RIR, Cardinale V, Kendall TJ, Avila MA, Guido M, Coulouarn C, Braconi C, Frampton AE, Bridgewater J, Overi D, Pereira SP, Rengo M, Kather JN, Lamarca A, Pedica F, Forner A, Valle JW, Gaudio E, Alvaro D, Banales JM, Carpino G. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions. Gut 2022:gutjnl-2022-327099. [PMID: 35580963 DOI: 10.1136/gutjnl-2022-327099] [Reference Citation Analysis]
10 Zhang MY, Luo M, He K, Xia XM, Wang JP. NTCP Change in Rats of Hilar Cholangiocarcinoma and Therapeutic Significance. Technol Cancer Res Treat 2022;21:15330338221109646. [PMID: 35730199 DOI: 10.1177/15330338221109646] [Reference Citation Analysis]